Brief: Spago Nanomedical Q3 operating loss widens to SEK 1.9 mln
Nov 8 (Reuters) - SPAGO NANOMEDICAL AB (PUBL) SPAGO.ST :
* Q3 OPERATING LOSS SEK 1.9 MILLION VERSUS SEK 1.3 MILLION
YEAR
AGO
Source text for Eikon: ID:nWkr5RxGfd
Further company coverage: SPAGO.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Spago Nanomedical AB (publ)
See all newsBrief: Spago Nanomedical Announces Outcome Of Rights Issue
Brief: Spago Nanomedical Resolves On Rights Issue Of About SEK 16 Million
Sweden's Spago Nanomedical Q1 loss narrows
Brief: Spago Nanomedical Q1 Sales SEK 22 Thousand
Brief: Spago Nanomedical Says Tumorad-01 Study Meets Primary Endpoint Of Maximum Tolerated Dose